卵叶车前草治疗肠易激综合征的双盲研究。
Double blind study of ispaghula in irritable bowel syndrome.
作者信息
Prior A, Whorwell P J
机构信息
Dept of Medicine, University Hospital of South Manchester.
出版信息
Gut. 1987 Nov;28(11):1510-3. doi: 10.1136/gut.28.11.1510.
Abstract
A double blind placebo controlled trial of ispaghula husk in 80 patients with irritable bowel syndrome is reported. Global assessment judged treatment to be satisfactory in 82% of patients receiving ispaghula and 53% of the placebo group (p less than 0.02). Bowel habit was unchanged in the placebo group, while constipation significantly improved in patients taking ispaghula (p = 0.026). Transit time decreased significantly in those taking ispaghula compared with placebo (p = 0.001), especially in patients with initially high transit times. Abdominal pain and bloating improved in both groups, with no significant differences between ispaghula and placebo. Four of the eight withdrawals on ispaghula and 10 of the 15 withdrawals on placebo were because of treatment failure. Ispaghula significantly improves overall well being in patients with irritable bowel syndrome, and in those with constipation favourably affects bowel habit and transit time.
摘要
本文报道了一项针对80例肠易激综合征患者的关于卵叶车前草籽壳的双盲安慰剂对照试验。整体评估显示，接受卵叶车前草籽壳治疗的患者中有82%对治疗满意，而安慰剂组这一比例为53%（p<0.02）。安慰剂组的排便习惯未改变，而服用卵叶车前草籽壳的患者便秘情况显著改善（p = 0.026）。与安慰剂组相比，服用卵叶车前草籽壳的患者转运时间显著缩短（p = 0.001），尤其是初始转运时间较长的患者。两组患者的腹痛和腹胀情况均有所改善，卵叶车前草籽壳组与安慰剂组之间无显著差异。服用卵叶车前草籽壳的8例退出研究患者中有4例，服用安慰剂的15例退出研究患者中有10例是因为治疗失败。卵叶车前草籽壳能显著改善肠易激综合征患者的整体健康状况，对于便秘患者，它能有利地影响排便习惯和转运时间。
相似文献
1
Double blind study of ispaghula in irritable bowel syndrome.卵叶车前草治疗肠易激综合征的双盲研究。
Gut. 1987 Nov;28(11):1510-3. doi: 10.1136/gut.28.11.1510.
2
Ispaghula therapy in irritable bowel syndrome: improvement in overall well-being is related to reduction in bowel dissatisfaction.卵叶车前草治疗肠易激综合征：整体幸福感的改善与肠道不适的减轻有关。
J Gastroenterol Hepatol. 1990 Sep-Oct;5(5):507-13. doi: 10.1111/j.1440-1746.1990.tb01432.x.
3
Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight.肠易激综合征患者中卵叶车前子壳的最佳剂量：症状缓解与全肠道转运时间及粪便重量的相关性
Gut. 1987 Feb;28(2):150-5. doi: 10.1136/gut.28.2.150.
4
Breath methane in functional constipation: response to treatment with Ispaghula husk.功能性便秘患者的呼出气甲烷：对卵叶车前子壳治疗的反应
Neurogastroenterol Motil. 2015 Jul;27(7):945-53. doi: 10.1111/nmo.12568. Epub 2015 May 7.
5
6
[The efficacy of Plantago ovata as a regulator of intestinal transit. A double-blind study compared to placebo].
Rev Esp Enferm Dig. 1992 Jul;82(1):17-22.
7
Psyllium therapy in the irritable bowel syndrome. A double-blind trial.洋车前子治疗肠易激综合征。一项双盲试验。
Ann Intern Med. 1981 Jul;95(1):53-6. doi: 10.7326/0003-4819-95-1-53.
8
Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging.利用磁共振成像技术演示健康受试者和便秘受试者结肠容量、传输时间、食糜稠度以及对车前子壳的反应的差异。
Neurogastroenterol Motil. 2018 Sep;30(9):e13400. doi: 10.1111/nmo.13400. Epub 2018 Jul 30.
9
The effect of 'Zesy002' kiwifruit ( var. ) on gut health function: a randomised cross-over clinical trial.“Zesy002”猕猴桃（品种）对肠道健康功能的影响：一项随机交叉临床试验。
J Nutr Sci. 2019 May 3;8:e18. doi: 10.1017/jns.2019.14. eCollection 2019.
10
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.一项关于益生菌VSL#3对腹泻型肠易激综合征肠道转运及症状影响的随机对照试验。
Aliment Pharmacol Ther. 2003 Apr 1;17(7):895-904. doi: 10.1046/j.1365-2036.2003.01543.x.
引用本文的文献
1
The role and therapeutic effectiveness of seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer.种子壳（车前子壳）在胃肠道疾病预防和非药物治疗中的作用及疗效。第1部分。车前子壳在治疗肠易激综合征、溃疡性结肠炎和结直肠癌中的临床应用。
Prz Gastroenterol. 2024;19(2):121-126. doi: 10.5114/pg.2024.139209. Epub 2024 Apr 29.
2
Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments.慢性内脏痛：新的外周机制见解及由此产生的治疗方法。
Gastroenterology. 2024 Jun;166(6):976-994. doi: 10.1053/j.gastro.2024.01.045. Epub 2024 Feb 5.
3
Peak week recommendations for bodybuilders: an evidence based approach.健美运动员的巅峰周建议：一种基于证据的方法。
BMC Sports Sci Med Rehabil. 2021 Jun 13;13(1):68. doi: 10.1186/s13102-021-00296-y.
4
Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik.肠易激综合征管理指南：纪念维托尔德·巴尔尼克教授
Prz Gastroenterol. 2018;13(4):259-288. doi: 10.5114/pg.2018.78343. Epub 2018 Sep 19.
5
Management Strategies for Abdominal Bloating and Distension.腹部腹胀的管理策略
Gastroenterol Hepatol (N Y). 2014 Sep;10(9):561-71.
6
Effective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis.有效的便秘治疗改变的不仅仅是排便频率：一项系统评价与荟萃分析
J Neurogastroenterol Motil. 2016 Jan 31;22(1):31-45. doi: 10.5056/jnm15171.
7
Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website.基层医疗中肠易激综合征的管理：一项探索性随机对照试验中，比较了美贝维林、甲基纤维素、安慰剂和自我管理网站的结果。
BMC Gastroenterol. 2013 Apr 21;13:68. doi: 10.1186/1471-230X-13-68.
8
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.用于治疗肠易激综合征的容积性泻剂、抗痉挛药和抗抑郁药。
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD003460. doi: 10.1002/14651858.CD003460.pub3.
9
Does a self-management program change dietary intake in adults with irritable bowel syndrome?自我管理计划能否改变成人肠易激综合征患者的饮食摄入？
Gastroenterol Nurs. 2011 Mar-Apr;34(2):108-16. doi: 10.1097/SGA.0b013e31821092e8.
10
The treatment of irritable bowel syndrome.肠易激综合征的治疗。
Therap Adv Gastroenterol. 2009 Jul;2(4):221-38. doi: 10.1177/1756283X09104794.
本文引用的文献
1
Psyllium therapy in the irritable bowel syndrome. A double-blind trial.洋车前子治疗肠易激综合征。一项双盲试验。
Ann Intern Med. 1981 Jul;95(1):53-6. doi: 10.7326/0003-4819-95-1-53.
2
The irritable bowel.肠易激综合征
Gut. 1984 Mar;25(3):305-20. doi: 10.1136/gut.25.3.305.
3
What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?粗麦麸对肠易激综合征患者有什么益处？
Gut. 1984 Feb;25(2):168-73. doi: 10.1136/gut.25.2.168.
4
Double blind trial of ispaghula/poloxamer in the Irritable Bowel Syndrome.卵叶车前子/泊洛沙姆治疗肠易激综合征的双盲试验
Ir Med J. 1983 May;76(5):253.
5
A ne method for studying gut transit times using radioopaque markers.一种使用不透射线标记物研究肠道通过时间的新方法。
Gut. 1969 Oct;10(10):842-7. doi: 10.1136/gut.10.10.842.
6
Non-colonic features of irritable bowel syndrome.肠易激综合征的非结肠特征
Gut. 1986 Jan;27(1):37-40. doi: 10.1136/gut.27.1.37.
7
The effect of coarse wheat bran in the irritable bowel syndrome. A double-blind cross-over study.粗麦麸对肠易激综合征的影响。一项双盲交叉研究。
Scand J Gastroenterol. 1985 Apr;20(3):295-8. doi: 10.3109/00365528509091653.
8
The irritable bowel syndrome. Part I: clinical spectrum.肠易激综合征。第一部分：临床谱。
Clin Gastroenterol. 1977 Sep;6(3):607-22.
9
Wheat fibre and irritable bowel syndrome. A controlled trial.小麦纤维与肠易激综合征。一项对照试验。
Lancet. 1977 Aug 27;2(8035):417-8. doi: 10.1016/s0140-6736(77)90605-5.
10
A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome.一项关于麦麸对肠易激综合征症状影响的双盲试验。
Lancet. 1976 Feb 7;1(7954):270-2. doi: 10.1016/s0140-6736(76)91402-1.
Zotero 插件